Document Detail


Mycobacterial Ocular Inflammation: Delay in Diagnosis and Other Factors Impacting Morbidity.
MedLine Citation:
PMID:  23579549     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
IMPORTANCE The reported outcomes of ocular mycobacterial infection are commonly unfavorable. This study is among the first to elucidate factors associated with poor outcomes, as well as highlight the continued controversies in therapy, particularly the role of oral corticosteroids. OBJECTIVE To describe presentations and outcomes of mycobacterial ocular disease in the Midwestern United States. DESIGN Retrospective case series. SETTING A university-based uveitis clinic. PARTICIPANTS Twenty-six eyes of 17 patients with mycobacterial ocular inflammatory disease seen at University of Illinois at Chicago from 1995 to 2010. MAIN OUTCOME MEASURES Bivariate and regression analyses were performed to assess factors associated with delay in referral, relapse, and irreversible visual acuity loss (≤20/200). RESULTS Of 17 patients, 13 had isolated ocular disease, 1 had miliary tuberculosis (TB), 2 had TB lymphadenopathy, and 1 had active pulmonary TB. Fourteen had Mycobacterium tuberculosis and 3 had nontuberculous mycobacterial infection. Chest imaging was consistent with granulomatous disease in 46.7%. Average delay from ocular disease onset to uveitis service referral was 755.3 days. Posterior uveitis and non-Hispanic white race were associated with increased delay. A relapsing course was observed in posterior uveitis (odds ratio [OR], 20.0; 95% CI, 1.39-287; P = .03) and those treated with systemic steroids for eye disease (OR, 10.1; 95% CI,1.60-64.0; P = .01). Disease control was achieved in 81%, although 38.5% had profound visual loss, associated with age older than 50 years and delay in diagnosis. Patients diagnosed after 500 days from initial ocular symptoms were more likely to lose vision (OR, 20.0; 95% CI, 1.41-282; P = .03). CONCLUSIONS Ocular mycobacterial infection occurs in nonendemic areas and cannot be ruled out with negative chest imaging. Tuberculosis and atypical mycobacterial infection should be in the differential diagnosis of ocular inflammation, regardless of patient ethnicity. Significant delays exist in instituting antimicrobial treatment, associated with increased morbidity. Early referral is necessary for patients not responding appropriately to anti-inflammatory therapy.
Authors:
Sarju S Patel; Nehali V Saraiya; Howard H Tessler; Debra A Goldstein
Related Documents :
20608279 - Expressive behavior in parkinson's disease as a function of interview context.
17085239 - Nutritional risks to large-breed dogs: from weaning to the geriatric years.
24496239 - Angiographic validation of the american college of cardiology foundation-the society of...
8173519 - Validity and reliability of a quality-of-life instrument: the chronic respiratory disea...
11672809 - Neonatal glucocorticoids and the developing brain: short-term treatment with life-long ...
23150419 - Human susceptibility to legionnaires' disease.
19840369 - Overview of the alberta kidney disease network.
23062569 - Diabetes and cardiovascular disease: changing the focus from glycemic control to improv...
16600159 - The renin-angiotensin system and atherosclerosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-4-11
Journal Detail:
Title:  JAMA ophthalmology     Volume:  -     ISSN:  2168-6173     ISO Abbreviation:  JAMA Ophthalmol     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-4-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101589539     Medline TA:  JAMA Ophthalmol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-7     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors for suicidal ideation of the general population.
Next Document:  CdTe-TiO2 nanocomposite: an impeder of bacterial growth and biofilm.